Publications and Posters

How can MSI enhance our understanding of ASO distribution?
January 1, 2025  •  van der Vloet, L., Hilaire, P. B. S., Bouillod, C., Isin, E. M., Heeren, R. M. A., & Vandenbosch, M. (2025).   In Drug Discovery Today ...
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
September 18, 2024  •  Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma
Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response
May 29, 2024  •  Pearce, S.M.; Cross, N.A.; Smith, D.P.; Clench, M.R.; Flint, L.E.; Hamm, G.; Goodwin, R.; Langridge, J.I.; Claude, E.; Cole, L.M. Metabolites 2024, 14, 315. • Drug study, Multiomic, Multimodal, Tumor Spheroids
Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma
February 25, 2024  •  Stillger, M. N., Li, M. J., Hönscheid, P., von Neubeck, C., & Föll, M. C. (2024). In PROTEOMICS (Vol. 24, Issues 12–13). Wiley. • Multiomic and Multimodal techniques